Fedha

Hisa unazofuatilia
Mtazamo: Thamani itaongezeka kwa asilimia 40.0·Thamani itapungua kwa asilimia 20.0
Nenda kwenye kichupo cha uchanganuzi
BMY:NYSE
Bristol-Myers Squibb Co
US$ 58.55
-0.96%
(-0.57) Siku 1
12 Okt, 09:55:22 GMT -4  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BMY...
Fungua
US$ 60.11
Juu
US$ 60.68
Chini
US$ 58.53
Mtaji wa soko
119.60B
Wastani wa kiasi cha mauzo
11.39M
Kiasi cha mauzo ya hisa
2.08M
Gawio
4.30%
Mgawo wa faida wa kila robo mwaka
US$ 0.63
Tarehe ya kutojumuisha gawio
2 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
12.90
Juu kwa wiki 52
US$ 68.64
Chini kwa wiki 52
US$ 42.52
EPS
US$ 4.54
Beta
0.19
Hisa za wawekezaji
2.04B
Idadi ya wafanyakazi
elfu 32
Fungua
US$ 60.11
Juu
US$ 60.68
Chini
US$ 58.53
Mtaji wa soko
119.60B
Wastani wa kiasi cha mauzo
11.39M
Kiasi cha mauzo ya hisa
2.08M
Gawio
4.30%
Mgawo wa faida wa kila robo mwaka
US$ 0.63
Tarehe ya kutojumuisha gawio
2 Okt 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
12.90
Juu kwa wiki 52
US$ 68.64
Chini kwa wiki 52
US$ 42.52
EPS
US$ 4.54
Beta
0.19
Hisa za wawekezaji
2.04B
Idadi ya wafanyakazi
elfu 32
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Kuhusu Bristol-Myers Squibb Co
Afisa Mkuu Mtendaji (CEO)Chris Boerner
Wafanyakazielfu 32.5
Lilianzishwa1887
Makao makuuNew York, New York, Marekani
Sekta-
Tovutibms.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 21 waliotoa ukadiriaji wa hisa kwa BMY katika miezi 3 iliyopita
Nunua
Nunua
8
Shikilia
12
Uza
1
Utabiri wa miezi 12
Kulingana na wachanganuzi 21 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya BMY katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 58.55
US$ 82.00 (+40.05%)
Wastani
US$ 66.26 (+13.17%)
Chini kabisa
US$ 41.00 (-29.97%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Geoff Meacham
Citi
Hold
Maintained
US$ 70.00
+19.6%
10/09/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
US$ 75.00
+28.1%
10/08/2026
David Amsellem
Piper Sandler
Buy
Reiterated
US$ 82.00
+40.1%
10/09/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
US$ 66.00
+12.7%
10/09/2026
Louise Chen
Scotiabank
Hold
Reiterated
US$ 60.00
+2.5%
10/08/2026
Chris Schott
J.P. Morgan
Buy
Maintained
US$ 73.00
+24.7%
10/08/2026
Carter Gould
Cantor Fitzgerald
Hold
Reiterated
US$ 53.00
-9.5%
10/08/2026
Michael Yee
UBS
Buy
Maintained
US$ 80.00
+36.6%
10/09/2026
Terence Flynn
Morgan Stanley
Sell
Maintained
US$ 41.00
-30%
10/07/2026
David Risinger
Leerink Partners
Hold
Maintained
US$ 59.00
+0.8%
10/07/2026
Evan Seigerman
BMO Capital
Hold
Maintained
US$ 60.00
+2.5%
09/30/2026
Mohit Bansal
Wells Fargo
Hold
Maintained
US$ 65.00
+11%
09/29/2026
Trung Huynh
RBC Capital
Hold
Maintained
US$ 64.00
+9.3%
09/21/2026
Rajesh Kumar
HSBC
Hold
Maintained
US$ 65.00
+11%
09/10/2026
Courtney Breen
Bernstein
Hold
Maintained
-
-
08/20/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/14/2026
Emily Field
Barclays
Buy
Reiterated
US$ 75.00
+28.1%
08/11/2026
Jasper Hellweg
Argus Research
Buy
Upgraded
US$ 75.00
+28.1%
08/04/2026
Unknown Analyst
Berenberg Bank
Hold
Maintained
US$ 65.00
+11%
08/03/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
US$ 70.00
+19.6%
07/31/2026
Asad Haider
Goldman Sachs
Hold
Maintained
US$ 61.00
+4.2%
07/20/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ 73.00
+24.7%
06/01/2026
Unknown Analyst
TD Cowen
Hold
Maintained
US$ 57.00
-2.6%
05/18/2026
Unknown Analyst
Erste Group
Hold
Maintained
-
-
04/01/2026
Ripoti ya mwisho
30 Jul 2026
Kipindi cha Kifedha
Robo2 2026
US$ 2.04 / US$ 1.60
+27.74%umepitiliza
Mapato dhidi ya makadirio (USD)
12.97B / 11.74B
+10.53%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
12.22B
12.50B
11.49B
12.97B
Gharama ya bidhaa zilizouzwa
3.31B
3.51B
3.41B
3.71B
Gharama ya mapato
3.31B
3.51B
3.41B
3.71B
Gharama za utafiti na maendeleo
2.43B
2.56B
2.24B
2.54B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
1.79B
2.09B
1.61B
1.82B
Gharama ya uendeshaji
5.05B
5.47B
4.28B
4.80B
Jumla ya gharama za uendeshaji
8.36B
8.98B
7.69B
8.51B
Mapato ya uendeshaji
3.86B
3.52B
3.80B
4.46B
Mapato mengine yasiyo ya uendeshaji
529.00M
544.00M
125.00M
106.00M
EBT ikijumuisha vipengee visivyo vya kawaida
3.11B
1.47B
3.24B
4.09B
EBT bila kujumuisha vipengee visivyo vya kawaida
4.07B
3.86B
3.65B
4.35B
Gharama ya kodi ya mapato
919.00M
384.00M
561.00M
770.00M
Kiwango cha kodi kinachotumika
29.51%
26.12%
17.32%
18.84%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
2.20B
1.09B
2.68B
3.32B
Kiwango cha faida halisi
18.01%
8.69%
23.30%
25.57%
Mapato kwa kila hisa
1.63
1.26
1.58
2.04
Mapato ya riba na uwekezaji
161.00M
148.00M
104.00M
101.00M
Gharama ya riba
-482.00M
-432.00M
-406.00M
-403.00M
Jumla ya gharama halisi za riba
-321.00M
-284.00M
-302.00M
-302.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
4.91B
4.54B
4.41B
5.08B
Faida au hasara kutokana na uuzaji wa vipengee
-9.00M
-
-34.00M
-142.00M
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google